View Item 

Show simple item record

Investigating Safety And Preliminary Efficacy Of Afm13 Plus Pembrolizumab In Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure

dc.contributor.authorAnsell, S.M.
dc.contributor.authorBartlett, N.L.
dc.contributor.authorChen, R.W.
dc.contributor.authorHerrera, A.
dc.contributor.authorDomingo‐domenech, E.
dc.contributor.authorMehta, A.
dc.contributor.authorForero‐torres, A.
dc.contributor.authorGarcia‐sanz, R.
dc.contributor.authorArmand, P.
dc.contributor.authorDevata, S.
dc.contributor.authorRodriguez Izquierdo, A.
dc.contributor.authorLossos, I.S.
dc.contributor.authorReeder, C.B.
dc.contributor.authorSher, T.
dc.contributor.authorChoe‐juliak, C.
dc.contributor.authorPrier, K.
dc.contributor.authorSchwarz, S.E.
dc.contributor.authorStrassz, A.
dc.contributor.authorAlland, L.
dc.date.accessioned2019-06-20T17:05:04Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2019-06-20T17:05:04Z
dc.date.issued2019-06
dc.identifier.citationAnsell, S.M.; Bartlett, N.L.; Chen, R.W.; Herrera, A.; Domingo‐domenech, E. ; Mehta, A.; Forero‐torres, A. ; Garcia‐sanz, R. ; Armand, P.; Devata, S.; Rodriguez Izquierdo, A.; Lossos, I.S.; Reeder, C.B.; Sher, T.; Choe‐juliak, C. ; Prier, K.; Schwarz, S.E.; Strassz, A.; Alland, L. (2019). "Investigating Safety And Preliminary Efficacy Of Afm13 Plus Pembrolizumab In Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure." Hematological Oncology 37(S2): 177-178.
dc.identifier.issn0278-0232
dc.identifier.issn1099-1069
dc.identifier.urihttps://hdl.handle.net/2027.42/149522
dc.publisherWiley Periodicals, Inc.
dc.titleInvestigating Safety And Preliminary Efficacy Of Afm13 Plus Pembrolizumab In Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbsecondlevelNeurosciences
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelOphthalmology
dc.subject.hlbsecondlevelOtolaryngology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/149522/1/hon134_2629.pdf
dc.identifier.doi10.1002/hon.134_2629
dc.identifier.sourceHematological Oncology
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hon134_2629.pdf
Size:
171.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.